@misc{indiciae57c0f0511978,
  title = {Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.},
  author = {Joseph D Buxbaum and Edward I Cullen and Lawrence T Friedhoff},
  year = {2002},
  doi = {10.2741/a739},
  url = {https://pubmed.ncbi.nlm.nih.gov/11900994/},
  note = {Source identifier: 11900994}
}